FDC's Q2 FY 2025-26 Quarterly Results

Result Summary

• FDC Ltd reported a 27.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 10.0%.
• Its expenses for the quarter were down by 13.1% QoQ and 0.6% YoY.
• The net profit decreased 76.6% QoQ and decreased 60.6% YoY.
• The earnings per share (EPS) of FDC Ltd stood at 1.75 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

FDC Ltd is a pharmaceutical company primarily engaged in the development, manufacturing, and marketing of pharmaceutical products. The company is known for its wide range of healthcare offerings, including formulations and active pharmaceutical ingredients (APIs). FDC Ltd operates within the pharmaceutical industry, which is characterized by high levels of regulation and competition. While specific recent developments about the company are not provided here, companies in this sector often focus on research and development to introduce new products and improve existing ones. FDC Ltd is likely impacted by industry trends such as innovation in drug development, regulatory changes, and shifts in consumer demand.

Revenue

In the second quarter of the fiscal year 2026 (Q2FY26), FDC Ltd reported a total income of ₹493.66 crores. This represents a decrease of 27.8% quarter-over-quarter (QoQ) from the previous quarter (Q1FY26), where total income was ₹683.91 crores. Comparatively, on a year-over-year (YoY) basis, total income declined by 10% from ₹548.55 crores in Q2FY25. The revenue figures highlight a downward trend in income both sequentially and annually. Such fluctuations in revenue can be influenced by various factors including market dynamics, product demand, and operational performance within the industry.

Profitability

FDC Ltd's profitability metrics have experienced significant changes over the period under review. The profit before tax (PBT) for Q2FY26 was ₹38.09 crores, reflecting a substantial decline of 76.2% QoQ from the ₹159.78 crores reported in Q1FY26. Year-over-year, the PBT decreased by 57.7% from ₹90.00 crores in Q2FY25. Following this, the tax expense for Q2FY26 was ₹9.72 crores, which decreased by 74.7% QoQ and 45.9% YoY. Consequently, the profit after tax (PAT) stood at ₹28.37 crores, marking a decrease of 76.6% QoQ and 60.6% YoY from the previous corresponding periods. The earnings per share (EPS) also mirrored this trend, decreasing to ₹1.75 in Q2FY26 from ₹7.45 in Q1FY26 and ₹4.43 in Q2FY25, with declines of 76.5% QoQ and 60.5% YoY.

Operating Metrics

The total expenses for FDC Ltd in Q2FY26 were ₹455.57 crores. This indicates a decrease of 13.1% QoQ from the expenses of ₹524.14 crores in Q1FY26 and a slight decline of 0.6% YoY from ₹458.55 crores in Q2FY25. The reduction in expenses is notable when viewed in conjunction with the revenue and profitability figures. The operating metrics, including total income and expenses, influence the overall financial health and operational efficiency of the company. The trends observed could be a result of internal cost management strategies or external market conditions impacting the company's operations within the quarter.